Redx Pharma plc - Share Purchase by Chairman
RNS Number: 0858 M Redx Pharma plc 25 April 2018 REDX PHARMA PLC. Alderley Park, 25 April 2018 Redx, the drug discovery and development company focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Executive Chairman, has today acquired 150,000 Redx ordinary shares at a price of 11 pence per share. Redx is a UK biotechnology company whose...
RNS Number: 0858 M [[Redx Pharma plc|redx-pharma-plc]] 25 April 2018 REDX PHARMA PLC. Alderley Park, 25 April 2018 Redx, the drug discovery and development company focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Executive Chairman, has today acquired 150,000 Redx ordinary shares at a price of 11 pence per share. Redx is a UK biotechnology company whose...